Pharmacists in Egg Harbor City, NJ Accepting Medicare
6 Pharmacists found. Showing 1 - 6
 Samer Awad Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1006 White Horse Pike, Egg Harbor City, NJ 08215 Phone: 609-965-0520 |
 Aanal Shah Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1006 White Horse Pike, Egg Harbor City, NJ 08215 Phone: 609-965-9807 |
Caitlin Acord, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 611 Havana Ave, Egg Harbor City, NJ 08215 Phone: 609-442-2271 |
Heather Lynn Fascia, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4810 Old Egg Harbor Rd, Egg Harbor City, NJ 08215 Phone: 609-965-6336 |
Mrs. Mary Ann Copperman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1006 White Horse Pike, Egg Harbor City, NJ 08215 Phone: 609-965-0520 Fax: 609-965-1953 |
Widlyne Ruffin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 350 Philadelphia Ave, Egg Harbor City, NJ 08215 Phone: 609-445-4423 |
News Archive
New microfluidic device helps extract rare target cells from background cells
A team of researchers from University of Cincinnati in Cincinnati, OH have developed a novel microfluidic device, which combines the inertial effect of fluid and microscale vortices generated in microchambers, to achieve simultaneous double sorting of rare target cells and removal of background cells.
Nicotine promotes growth of established tumors
While it is established that nicotine by itself is not carcinogenic, researchers have now shown that nicotine promotes cell proliferation and the progression of tumors already initiated by tobacco carcinogens.
Genzyme reports five-year patient data from Phase 2 multiple sclerosis trial
Genzyme Corporation today reported five-year patient data from its completed Phase 2 multiple sclerosis (MS) trial. This sub-group analysis found that nearly 90 percent of alemtuzumab-treated patients were free of sustained accumulation of disability, and that patients receiving alemtuzumab also maintained improved mean disability scores and a low risk of relapse over the 60-month follow-up period.
New clinical trial on breast cancer may help treat and control disease
A new clinical trial at Sanford Health is exploring how genetic changes that occur during breast cancer might help health care providers better identify, treat and control the disease.
Final tests negative for mad cow disease in the U.S.
The U.S. Department of Agriculture's (USDA) National Veterinary Services Laboratories (NVSL) in Ames, Iowa, has determined that the non-definitive test result reported on July 27 is negative for BSE. Tests conducted by the Veterinary Laboratories Agency in Weybridge, England, are also negative for BSE.
› Verified 6 days ago
Pharmacists
Clinical Social Workers
Occupational Therapists
Counselors
Psychologists
Dentists